No Detail Found!

An Observational Study on The Effects Of Improvised Cpap (Icpap) In Cardiovascular Diseases With Acute Respiratory Failure

Author(s)
Maheen Wahaj National Institute of Cardiovascular Diseases, Karachi, Pakistan
Lalarukh Taimoor National Institute of Cardiovascular Diseases, Karachi, Pakistan
Mujtaba Hasan National Institute of Cardiovascular Diseases, Karachi, Pakistan
Komal Baloch National Institute of Cardiovascular Diseases, Karachi, Pakistan
Urwah Ikhlaq DOW University Hospital, OJHA Campus, Karachi, Pakistan
Muhammad Imran Ansari National Institute of Cardiovascular Diseases, Karachi, Pakistan
Saif Naveed Husain Ziauddin Medical University, Karachi, Pakistan
Masooma Aqeel Aga Khan University, Karachi, Pakistan
Madiha Umair National Institute of Cardiovascular Diseases, Karachi, Pakistan
Jawed Abubaker National Institute of Cardiovascular Diseases, Karachi, Pakistan
Nawal Salahuddin National Institute of Cardiovascular Diseases, Karachi, Pakistan
Abstract
Objectives: This study describes three surges of COVID-19 hypoxemic respiratory failure and our experience with using iCPAP in patients with cardiovascular diseases at a tertiary cardiac care centre. Methodology: This observational study was conducted from March 23rd 2020 to May 31st 2021, at The National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. This is an analysis of data from the PRICE Network Registry. Data was collected for all adult patients with cardiovascular diseases admitted with acute hypoxemic respiratory failure and a confirmed diagnosis of SARS CoV-2. Results: Among 362 patients with 'severe' or 'critical' COVID-19 were hospitalized; 163 (45%) in the 1st surge, 92 (25.4%) in the 2nd and 107 (29.6 %) in the 3rd surge. All-cause mortality was 118 (32.6%). iCPAP was used in 39% (141) patients, 19% (69) patients required oxygen only, 25.4% (92) were on BiPAP support and 16.6% (60) were intubated. 'iCPAP failure' occurred in 48/141 (34%) patients. iCPAP failure occurred in patients with higher APACHE II scores (16.3 ±5.7 v/s 21.3±6, p =0.001), lower ROX index on admission (5.0±2.2 vs. 10.4±5.4, p=0.001), lesser degree of improvement in ROX index at 48 hours (Day 3 ROX 18.7±8.9 vs. 9.9±6.3, p=0.001). Mortality rate on iCPAP was 44 (31.2%). Conclusion: COVID-19 outcomes in a resource-limited setting in patients having cardiovascular diseases, appear comparable to global reports. A modification of standard CPAP (iCPAP) appeared to be safe and effective. This modification of standard CPAP (iCPAP) identifies an option for resource-limited or resource-exhausted critical care units.
Publication Details
Page(s) 266-273
DOI DOI not available
Published Journal: Pakistan Heart Journal, Volume: 55, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
attitude, Heart failure, influenza vaccine, knowledge of influenza
0

Citations

0

Downloads

42

Views